Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-002180
Filing Date
2025-02-12
Accepted
2025-02-12 16:10:38
Documents
1
Period of Report
2025-02-10

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 8577
  Complete submission text file 0001062993-25-002180.txt   10190
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Issuer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BIODELIVERY SCIENCES INTERNATIONAL, INC. 4131 PARKLAKE AVE SUITE 225 RALEIGH NC 27612
Business Address
Smith Thomas B (Reporting) CIK: 0001748462 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37372 | Film No.: 25614892